Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
04/2009
04/16/2009WO2007144900A3 Carvedilol phosphate sesquihydrate
04/16/2009WO2006102126A3 Inhibitors of isoprenylcysteine carboxyl methyltransferase
04/16/2009US20090099370 Crystalline Form of Perindopril Erbumine
04/16/2009US20090099248 Inhibitors of d-amino acid oxidase
04/16/2009US20090099247 Use of tetramic acid derivatives for controlling pets by drenching, drip application, dip application or soil injection
04/16/2009US20090099236 treatment of depression, anxiety, genitourinary diaorders, pain; monoamine reuptake inhibitors, triple and/or dual reuptake inhibitors of norepinephrine, serotonin, and dopamine; methyl-[3-(3-methyl-1H-indazol-5-yl)-3-phenyl- propyl]-amine
04/16/2009US20090099186 Inhibitors of viral replication
04/16/2009US20090099180 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
04/16/2009US20090099164 Phenylaminopropanol Derivatives and Methods of Their Use
04/16/2009US20090099139 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
04/16/2009US20090098410 Trimethine Dimer Compound and Optical Recording Medium Using the Same
04/16/2009US20090096356 Light-emitting device material and light-emitting device
04/16/2009CA2709224A1 Thrombopoietin receptor agonist (tpora) kills acute human myeloid leukemia cells
04/16/2009CA2701519A1 Piperidine and piperazine derivatives
04/15/2009EP2046789A2 Labelled analogues of halobenzamides as radiopharmaceuticals
04/15/2009EP2046742A1 Benzo [f] isoindoles as ep4 receptor agonists
04/15/2009EP2046741A1 Indoles as 5-ht6 modulators
04/15/2009EP2046740A1 Compounds having crth2 antagonist activity
04/15/2009EP1432680B1 Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones
04/15/2009EP1378246B1 sPLA2 INHIBITORS FOR ARTERIOSCLEROSIS
04/15/2009CN101410373A Bridged cyanine compounds and optical recording materials containing the same
04/15/2009CN101407491A Isoindole compounds and uses thereof
04/15/2009CN101407490A 2-benzoxy acrylic ester compounds and uses thereof
04/15/2009CN101407489A 2-alkyl acrylate compounds and uses thereof
04/15/2009CN101406469A Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
04/15/2009CN100478331C Inhibitors of cathepsin s
04/14/2009US7517990 Method for deuteration of a heterocyclic ring
04/14/2009US7517988 N-hydroxy-4-[2-(benzofuran-2-ylcarbonylamino)ethylsulfonyl]-benzamide; hepatitis C; inhibitors of histone deacetylase
04/14/2009US7517987 Interleukin converting enzyme inhibitors such as 5-Fluoro-4-oxo-3-(2-(6-oxo-6H-pyrimidin-1-yl)-butyrylamino)-pentanoic acid, administered as modulators of cell apoptosis and inflammation
04/14/2009US7517910 Alkoxyphenylpropanoic acid derivatives
04/14/2009US7517906 Dimeric IAP inhibitors
04/14/2009US7517905 highly potent; side effect reduction; for the treatment of diseases of the respiratory, urinary and gastrointestinal systems; 3-(2-Methoxy-5-methylphenyl)-3-phenylpropionic acid-(3-benzyl-3-azabicyclo[3.1.0]hex-6-yl-carbamoyl)methyl ester; condensation; deprotection
04/14/2009US7517899 Phenylaminopropanol derivatives and methods of their use
04/14/2009CA2380980C Mutilin derivatives and their use as antibacterials
04/14/2009CA2253211C Sulfonamide-substituted fused 5-membered ring compounds, their use as a medicament, and pharmaceutical preparations comprising them
04/09/2009WO2009044245A2 Production of monatin enantiomers
04/09/2009WO2009044244A2 Production of monatin enantiomers
04/09/2009WO2009044019A2 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof
04/09/2009WO2009043986A1 Three-functional pseudo-peptidic reagent, and uses and applications thereof
04/09/2009WO2009043884A1 Azabicyclo [3. 1. 0] hexyl derivatives as modulators of dopamine d3 receptors
04/09/2009WO2008072257A3 Process for the preparation of indole derivatives
04/09/2009WO2006085338A3 Novel polymorphic forms of fluvastatin sodium and process for preparing the same
04/09/2009WO2006050120A3 Synthesis of cox-2 and faah inhibitors
04/09/2009US20090093541 Melanin eliminator preparation
04/09/2009US20090093485 Novel Sulphonamide Derivatives as Glucocorticoid Receptor Modulators for the Treatment of Inflammatory Diseases
04/09/2009US20090093469 Phenylaminopropanol Derivatives and Methods of Their Use
04/09/2009US20090092782 Indole compound, optical filter and optical recording material
04/09/2009US20090091240 Compound containing fused ring and organic electroluminescent element employing the same
04/09/2009US20090089939 Indole-derived styryl dye comprising an alkylene linker, a dye composition comprising this dye, and a process for lightening keratin materials using this dye
04/09/2009CA2701421A1 Production of monatin enantiomers
04/09/2009CA2701153A1 Production of monatin enantiomers
04/09/2009CA2701114A1 Production of monatin stereoisomers
04/09/2009CA2694843A1 Three-functional pseudo-peptidic reagent, and uses and applications thereof
04/09/2009CA2694322A1 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof
04/08/2009EP2045806A2 Use of indolinium diazamethine cations for optical data recording
04/08/2009EP2045241A1 Fluoro substituted cycloalkanoindoles and their use as prostaglandin D2 receptor antagonists
04/08/2009EP2045240A1 Halogen alkoxy spirocyclic tetram and tetron acid derivatives
04/08/2009EP2045239A1 Novel derivatives of phthalimide as histone deacetylase inhibitors
04/08/2009EP2045238A1 Bridged cyanine compounds and optical recording materials containing the same
04/08/2009EP2044958A2 Pharmaceutical composition for treating arteriosclerosis
04/08/2009EP2044019A1 3-oxoisoindoline-1-carboxamide derivatives as analgesic agents
04/08/2009EP2044018A1 Substituted n-bicyclicalkyl bicyclic carboxyamide compounds
04/08/2009EP2044017A2 Substituted phenyl acetic acids as dp-2 antagonists
04/08/2009EP2044016A2 4-heteroaryl-substituted 1-aminocyclohexane-1-and cyclohexene-1-derivatives having effects on the opiod receptor system
04/08/2009EP2044010A1 New pharmaceutical intermediates in the synthesis of ace- inhibitors and the use thereof
04/08/2009EP2043444A1 Chemical compounds
04/08/2009EP1551830B1 Heterocyclically substituted indolinones and their use as receptor tyrosine kinase inhibators
04/08/2009EP1513811B1 Non-peptidic brs-3 agonists
04/08/2009EP1415986B1 Spiro isobenzofuranes as neuropeptide y receptor antagonists
04/08/2009EP0931063B3 N-substituted indol-3-glyoxylamid with antiasthmatic, antiallergic and immunosuppressive/immunomodulating effect
04/08/2009CN101405264A Piperidinyl, indolyl, pirinidyl, morpholinyl and benzimidazolyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases
04/08/2009CN101405263A Cannibinoid receptor modulators
04/08/2009CN101402554A 2- and 2,5-substituted phenylketo-enols
04/08/2009CN100475818C Indolinospiropyran compounds and methods for manufacture
04/08/2009CN100475798C Sulfonate derivatives and the use therof as latent acids
04/08/2009CN100475778C Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
04/08/2009CN100475759C Novel aromatic compound and organic electroluminescnet element containing the same
04/08/2009CN100475206C Compounds useful in the treatment of anthrax and inhibiting lethal factor
04/07/2009US7514543 Immunoglobulin fusion for use as therapeutic tool in prevention and treatment of chronic progression of atherosclerosis in diabetic patients
04/07/2009US7514468 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions
04/07/2009US7514467 Novel polymorphic form IV and solvate; precipitation from ethyl acetate
04/07/2009US7514457 Substituted aryloxymethyl bicyclicmethyl acetamide compounds
04/07/2009CA2341991C Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonists
04/07/2009CA2267947C Preparation of 3-fluoro oxindole derivatives
04/07/2009CA2217737C Thf-containing sulfonamide inhibitors of aspartyl protease
04/02/2009WO2009042485A1 Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor biological activity
04/02/2009WO2009041482A1 Acetylene compound
04/02/2009WO2009040314A2 Novel heteroaryl-substituted acetone derivatives, suitable for inhibiting phospholipase a2
04/02/2009WO2009039975A1 Halogen alkoxy spirocyclic tetramic and tetronic acid derivatives
04/02/2009WO2009039635A1 Methods of modulating neurotrophin-mediated activity
04/02/2009WO2008157537A3 Compositions and methods of use for treating or preventing lipid related disorders
04/02/2009US20090088578 Nuclear magnetic resonance imaging of selective small molecule drugs as contrast agents
04/02/2009US20090088577 Production of monatin enantiomers
04/02/2009US20090088570 Organic electroluminescent device
04/02/2009US20090087829 Production of monatin enantiomers
04/02/2009US20090087759 Oxime Ester Photoinitiators
04/02/2009US20090087409 Viral Polymerase Inhibitors
04/02/2009US20090087376 Heterocyclic Dye Compounds For In Vivo Imaging And Diagnosis Of Alzheimer's Disease
04/02/2009US20090084441 Dye-sensitized photoelectric conversion device
04/02/2009DE102007045476A1 Neue heteroarylsubstituierte Acetonderivate, geeignet zur Hemmung der Phospholipase A2 New heteroaryl acetone derivatives useful for inhibiting phospholipase A2